Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine
Issue link: http://clinicalomics.epubxp.com/i/798822
www.clinicalomics.com March/April 2017 Clinical OMICs 41 If asked, most doctors would tell you that they've never practiced any- thing but personalized and precision medicine to the best of their ability, Parker said . But now, those terms have taken on new meaning . Personalized medicine has become as personal as a patient's unique genetic code, and this has provided doctors with an arsenal of new tools to guide wellness and treat diseases . Mayo Clinic began its personal- ized medicine program in 2013, with one aspect of that program providing genetic sequencing to help diagnose rare diseases in patients that have heretofore been undiagnosed . Some of these patients have piled up $2 million in MRIs, resulting in no diagnostic conclusions, Parker said . When Mayo began using genetics to analyze these patients, the clinic was able to diag- nose roughly 20% of them . This not only gave patients hope, but payers could begin to appreciate the poten- tial savings made possible through genetic testing in this scenario . Stage 4 cancer is another area where Mayo has seen payers willing to pay for genome analysis, Parker added . According to Franziska Moeckel, assistant vice president of personal- ized health at the Inova Translational Medicine Institute (ITMI) and co-au- thor of the PMC study, precision med- icine enables individuals to live longer and transforms healthcare from reac- tive to predictive . Inova Health System, a nonprofit health center located in Falls Church, Virginia, launched ITMI in 2011. The institute provides a combination of clinical care and bioinformatics, backed up by an in-house genomics laboratory . ITMI is part of the Inova Center for Personalized Health, which connects researchers, clinicians, and consumers to integrate genomic research for patient care, prevention, and wellness, Moeckel said . The implementation of predictive medicine is complex and requires find- ing and combining solutions across a gamut of disciplines, including medi- cal, financial, legal, marketing and IT, to name a few . "It's a new paradigm . It has so many different players," Moeckel noted . "You have to work as a team to make it an effective process." No matter what the challenges, Inova is dedicated to precision med- icine because "these investments will be fruitful for years to come," she said . EHR Vendor Allscripts Spinoff 2bPrecise Unveils Precision Medicine Platform 2bPrecise, a subsidiary of electronic health record (EHR) company Allscripts, announced in February the general avail- ability of its EHR-agnostic, cloud-based precision medicine platform. The secure platform captures and stores genomic data, which it combines with research and clinical data, then pushes it to the point of care to provide clinical decision support. "As the pace of genomic discovery continues to accelerate, the mountain of genetic data—separated in clinical, lab or other systems—continues to grow," said Assaf Halevy, founder and CEO of 2bPrecise. "For patients to benefit from this expanding body of knowledge, we need to get the relevant insights into the hands of treating providers without dis- rupting their existing workflows. 2bPre- cise is the last-mile solution that closes this information gap, empowering phy- sicians to provide the most precise care." According to the company, which put the platform to test at early adopter orga- nizations such as the NIH and Holston Medical Group, the technology pro- vides a genomic repository, knowledge hub, and translational medicine fea- tures, all designed to fit within existing clinical workflows. xijian / Getty Images JohnnyGreig / Getty Images Helping to push precision medicine into the mainstream are growing diagnostic success rates relative to conventional diagnostic methods.